<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03388671</url>
  </required_header>
  <id_info>
    <org_study_id>17300080</org_study_id>
    <nct_id>NCT03388671</nct_id>
  </id_info>
  <brief_title>Laparoscopic Guided Transversus Abdominis Plane Block for Postoperative Analgesia After Pediatric Laparoscopic Surgery.</brief_title>
  <acronym>TAB</acronym>
  <official_title>Laparoscopic Guided Transversus Abdominis Plane Block for Postoperative Analgesia After Pediatric Laparoscopic Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study will be to investigate the safety and analgesic efficacy of Transversus
      Abdominis Plane (TAB) Block versus psoas block blockade. Both blocks will be administered
      surgically and guided by the laparoscopy screen in children undergoing laparoscopic surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Transversus abdominis plane (TAP) block is a promising effective method for postoperative
      pain control after major abdominal surgery. TAP block provides analgesia by inhibiting nerve
      conduction from the anterior abdominal wall arising from the intercostal nerves, subcostal
      nerves, and first lumbar nerve (T6-L1). Using a landmark technique, it is easily performed,
      but its popularity has decreased because of reduced efficacy due to inaccurate injection and
      the potential for intra-peritoneal organ damage. Ultrasound-guided TAP block provides better
      results and fewer complications, but it requires experienced operators. Surgically
      administered TAP (sTAP) block guided by the video camera of the laparoscope is a simple
      technique and may cause no complications. Also, under laparoscopic guidance, block of
      ilioinguinal, iliohypogastric, and genitofemoral nerves can be possible with anesthetic
      injection in the plane between psoas major and the fasciae covering its anterior aspects
      [laparoscopic-assisted psoas (LAP) blockade].
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 25, 2017</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The aim of this study will be to investigate the safety and analgesic efficacy of Transversus Abdominis Plane (TAB) Block versus psoas blocks. Both blocks will be administered surgically and guided by the laparoscopy screen in children undergoing laparoscopic surgery.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>The data collection personnel and the patients' guardians will be blinded to the group assignment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>FLACC PAIN score</measure>
    <time_frame>36hours</time_frame>
    <description>postoperative FLACC pain scores.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>TAB Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided Transversus abdominis plane block.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Psoas Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided psoas block.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TAB Block</intervention_name>
    <description>patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided TAB Block</description>
    <arm_group_label>TAB Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Psoas Block</intervention_name>
    <description>patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided Psoas Block</description>
    <arm_group_label>Psoas Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided Psoas Block or TAB block</description>
    <arm_group_label>TAB Block</arm_group_label>
    <arm_group_label>Psoas Block</arm_group_label>
    <other_name>Bucain</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children (1-6 years) of both sexes undergoing elective laparoscopic surgeries that
             last &gt;30minutes (eg. undescended testis and inguinal hernia repair).

          -  Written consent, free and informed

        Exclusion Criteria:

          -  Significant respiratory, cardiac or renal disease

          -  BMI &gt;95th percentile for age.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hala S Abdelghaffar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor in anesthesia and intensive care department, faculty of medicine, Assiut university, Egypt.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hala S Abdelghaffar, MD</last_name>
    <phone>01003812011</phone>
    <phone_ext>+2088</phone_ext>
    <email>hallasaad@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Seham M Moeen, MD</last_name>
    <phone>01006386324</phone>
    <phone_ext>+2088</phone_ext>
    <email>seham.moeen@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Pediatric hospital, faculty of medicine, Assiut university</name>
      <address>
        <city>Assiut</city>
        <state>Assiut Governorate</state>
        <zip>715715</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hala S Abdelghaffar, MD</last_name>
      <phone>+201003812011</phone>
      <email>hallasaad@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Seham M Moeen, MD</last_name>
      <phone>01006386324</phone>
      <email>seham.moeen@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 25, 2017</study_first_submitted>
  <study_first_submitted_qc>December 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">January 3, 2018</study_first_posted>
  <last_update_submitted>December 25, 2017</last_update_submitted>
  <last_update_submitted_qc>December 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Hala Saad Abdel-Ghaffar</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

